Why Should Medtech Follow the Development of the In Vitro Diagnostics Market?

It doesn’t get much better than this for the In Vitro Diagnostics market. There have been multiple billion dollar acquisitions in this space, game-changing products launched, and decisive data from clinical trials. While some medtech markets are actually in decline, such as diagnostic imaging and orthopedic markets due to healthcare price pressure and other market forces, the market for diagnostics growing and will continue to grow to 2020 and beyond. (Chart 1). Read more